Markets
IREN Stock Soars 23% After AI Cloud Sales Reach $200 Million
The rebound follows a steep selloff, while IREN still expects to finance $6 billion of planned capital spending.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Markets
The rebound follows a steep selloff, while IREN still expects to finance $6 billion of planned capital spending.
Markets
Service revenue grew 60% from a year earlier, while adjusted earnings per share declined.
Markets
Delayed federal deployments remove about $130 million from the outlook, while faster inventory spending cuts expected free cash flow.
Markets
The DNA-medicine developer priced common shares at $1.05 each and expects the offering to close Monday.
Markets
The automotive-chip supplier forecasts further revenue growth and expects adjusted profitability by the second quarter of 2027.
Markets
Management defended a planned $650 million to $700 million Predictions investment as analysts questioned its legal-risk assumptions.
Earnings
Shield screening revenue grew 180%, while higher spending accompanied an increase in the company's annual sales outlook.
Deals
Margins improved, but Synaptics will skip its earnings call and financial outlook because of the pending all-cash acquisition.
Earnings
The drug-delivery company raised its earnings outlook and completed $400 million in buybacks; shares fell about 4% in Friday trading.
SEC Filings
Worldwide sales rose 14% on both reported and currency-neutral bases, while Tandem kept its annual forecast unchanged.
Earnings
Management cut its adjusted earnings outlook as analysts questioned whether prediction-market customers would repay the spending.
SEC Filings
The cell-therapy developer expects autoimmune-disease results Monday and a lymphoma trial update in mid-2027.